• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖脂代谢紊乱中的代谢性炎症:发病机制与治疗。

Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment.

机构信息

Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, China.

Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, China.

出版信息

Biomed Pharmacother. 2023 May;161:114545. doi: 10.1016/j.biopha.2023.114545. Epub 2023 Mar 20.

DOI:10.1016/j.biopha.2023.114545
PMID:36948135
Abstract

The public health issue of glucolipid metabolic disorders (GLMD) has grown significantly, posing a grave threat to human wellness. Its prevalence is rising yearly and tends to affect younger people. Metaflammation is an important mechanism regulating body metabolism. Through a complicated multi-organ crosstalk network involving numerous signaling pathways such as NLRP3/caspase-1/IL-1, NF-B, p38 MAPK, IL-6/STAT3, and PI3K/AKT, it influences systemic metabolic regulation. Numerous inflammatory mediators are essential for preserving metabolic balance, but more research is needed to determine how they contribute to the co-morbidities of numerous metabolic diseases. Whether controlling the inflammatory response can influence the progression of GLMD determines the therapeutic strategy for such diseases. This review thoroughly examines the role of metaflammation in GLMD and combs the research progress of related therapeutic approaches, including inflammatory factor-targeting drugs, traditional Chinese medicine (TCM), and exercise therapy. Multiple metabolic diseases, including diabetes, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, and others, respond therapeutically to anti-inflammatory therapy on the whole. Moreover, we emphasize the value and open question of anti-inflammatory-based means for treating GLMD.

摘要

糖脂代谢紊乱(GLMD)这一公共卫生问题日益严重,严重威胁着人类健康。其发病率逐年上升,且趋于年轻化。代谢相关性炎症是调控机体代谢的重要机制,通过涉及 NLRP3/caspase-1/IL-1、NF-κB、p38MAPK、IL-6/STAT3、PI3K/AKT 等多条信号通路的复杂多器官串扰网络,影响全身代谢调控。众多炎症介质对于维持代谢平衡至关重要,但尚需更多研究来明确其在多种代谢性疾病共病中的作用。调控炎症反应是否能影响 GLMD 的进展,决定了此类疾病的治疗策略。本文深入探讨了代谢相关性炎症在 GLMD 中的作用,并梳理了相关治疗方法的研究进展,包括炎症因子靶向药物、中药(TCM)和运动疗法。整体而言,多种代谢性疾病,包括糖尿病、非酒精性脂肪性肝病(NAFLD)、心血管疾病等,对抗炎治疗均有反应。此外,我们强调了基于抗炎的 GLMD 治疗方法的价值和存在的问题。

相似文献

1
Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment.糖脂代谢紊乱中的代谢性炎症:发病机制与治疗。
Biomed Pharmacother. 2023 May;161:114545. doi: 10.1016/j.biopha.2023.114545. Epub 2023 Mar 20.
2
Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine.中西医结合防治糖脂代谢病的研究进展
Chin J Integr Med. 2017 Jun;23(6):403-409. doi: 10.1007/s11655-017-2811-3. Epub 2017 Aug 10.
3
Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders.糖脂代谢紊乱中的下丘脑-垂体-肾上腺轴。
Rev Endocr Metab Disord. 2020 Dec;21(4):421-429. doi: 10.1007/s11154-020-09586-1. Epub 2020 Sep 5.
4
Distinct metabonomic signatures of Polygoni Multiflori Radix Praeparata against glucolipid metabolic disorders.制何首乌对糖脂代谢紊乱的代谢组学特征研究
J Pharm Pharmacol. 2021 Apr 27;73(6):796-807. doi: 10.1093/jpp/rgab012.
5
Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.基于网络药理学和小型猪验证的复方珍珠调脂胶囊治疗 2 型糖尿病合并非酒精性脂肪肝病的分子机制。
J Ethnopharmacol. 2021 Jun 28;274:114056. doi: 10.1016/j.jep.2021.114056. Epub 2021 Mar 23.
6
GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease.生长分化因子 15,糖脂代谢紊乱和心血管疾病的未来治疗靶点。
Biomed Pharmacother. 2022 Feb;146:112582. doi: 10.1016/j.biopha.2021.112582. Epub 2021 Dec 24.
7
Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease.肝脏-脂肪组织相互作用:糖脂代谢疾病发病机制中的关键因素。
Chin J Integr Med. 2017 Jun;23(6):410-414. doi: 10.1007/s11655-017-2810-4. Epub 2017 Aug 10.
8
Regulating metabolic inflammation by nutritional modulation.通过营养调节来控制代谢性炎症。
J Allergy Clin Immunol. 2020 Oct;146(4):706-720. doi: 10.1016/j.jaci.2020.08.013. Epub 2020 Aug 22.
9
Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.中药单体治疗非酒精性脂肪性肝病的研究进展。
Eur J Pharmacol. 2021 May 5;898:173976. doi: 10.1016/j.ejphar.2021.173976. Epub 2021 Feb 24.
10
DIA-PRM Proteomic Analysis of Phlegm-Dampness Constitution with Glucolipid Metabolic Disorders by the Intervention of Hua Tan Qu Shi Recipe.化痰祛湿方干预糖脂代谢紊乱痰湿体质的 DIA-PRM 蛋白质组学分析。
Biomed Res Int. 2022 Dec 23;2022:6464431. doi: 10.1155/2022/6464431. eCollection 2022.

引用本文的文献

1
UPLC-MS/MS Metabolomics Reveals Babao Dan's Mechanisms in MASH Treatment with Integrating Network Pharmacology and Molecular Docking.超高效液相色谱-串联质谱代谢组学结合网络药理学和分子对接揭示八宝丹治疗急性重症胰腺炎的机制
Pharmaceuticals (Basel). 2025 Jul 25;18(8):1111. doi: 10.3390/ph18081111.
2
Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy.4-甲基伞形酮对雄黄-黄连中FAS和HAS2/3的双重抑制揭示了肝癌治疗的代谢检查点。
Nat Prod Bioprospect. 2025 Aug 21;15(1):56. doi: 10.1007/s13659-025-00540-9.
3
Association between serum gastric biomarkers and metabolic syndrome.
血清胃生物标志物与代谢综合征之间的关联。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Apr 28;50(4):641-650. doi: 10.11817/j.issn.1672-7347.2025.240324.
4
Systemic immune indicators for predicting renal damage in newly diagnosed type 1 diabetic children.预测新诊断1型糖尿病儿童肾损伤的全身免疫指标
World J Diabetes. 2025 May 15;16(5):104482. doi: 10.4239/wjd.v16.i5.104482.
5
Nonlinear relationship between serum high sensitivity C reactive protein to high density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease.血清高敏C反应蛋白与高密度脂蛋白胆固醇比值与非酒精性脂肪性肝病之间的非线性关系。
Sci Rep. 2025 May 27;15(1):18579. doi: 10.1038/s41598-025-03528-0.
6
Integrative Analysis and Experimental Validation Reveal FCGR1A and ITGAL as Key Inflammatory Biomarkers in Proliferative Diabetic Retinopathy.综合分析与实验验证揭示FCGR1A和ITGAL是增殖性糖尿病视网膜病变中的关键炎症生物标志物。
J Inflamm Res. 2025 May 13;18:6229-6243. doi: 10.2147/JIR.S519725. eCollection 2025.
7
Association of the inflammatory burden index with the risk of pre-diabetes and diabetes mellitus: a cross-sectional study.炎症负担指数与糖尿病前期和糖尿病风险的关联:一项横断面研究。
BMC Endocr Disord. 2025 Mar 26;25(1):82. doi: 10.1186/s12902-025-01911-6.
8
Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway.藤茶二氢杨梅素提取物改善小鼠糖脂代谢紊乱的分子机制:基于肝脏RNA测序及TLR4/MyD88/NF-κB通路
Int J Mol Sci. 2025 Feb 28;26(5):2169. doi: 10.3390/ijms26052169.
9
Mechanisms of inflammatory microenvironment formation in cardiometabolic diseases: molecular and cellular perspectives.心脏代谢疾病中炎症微环境形成的机制:分子与细胞视角
Front Cardiovasc Med. 2025 Jan 14;11:1529903. doi: 10.3389/fcvm.2024.1529903. eCollection 2024.
10
Red cell distribution width/albumin ratio as a marker for metabolic syndrome: findings from a cross-sectional study.红细胞分布宽度/白蛋白比值作为代谢综合征的标志物:一项横断面研究的结果。
BMC Endocr Disord. 2024 Oct 25;24(1):227. doi: 10.1186/s12902-024-01762-7.